1614 related articles for article (PubMed ID: 25432777)
1. Potential of fecal microbiota for early-stage detection of colorectal cancer.
Zeller G; Tap J; Voigt AY; Sunagawa S; Kultima JR; Costea PI; Amiot A; Böhm J; Brunetti F; Habermann N; Hercog R; Koch M; Luciani A; Mende DR; Schneider MA; Schrotz-King P; Tournigand C; Tran Van Nhieu J; Yamada T; Zimmermann J; Benes V; Kloor M; Ulrich CM; von Knebel Doeberitz M; Sobhani I; Bork P
Mol Syst Biol; 2014 Nov; 10(11):766. PubMed ID: 25432777
[TBL] [Abstract][Full Text] [Related]
2. Applying simple linear combination, multiple logistic and factor analysis methods for candidate fecal bacteria as novel biomarkers for early detection of adenomatous polyps and colon cancer.
Rezasoltani S; Sharafkhah M; Asadzadeh Aghdaei H; Nazemalhosseini Mojarad E; Dabiri H; Akhavan Sepahi A; Modarressi MH; Feizabadi MM; Zali MR
J Microbiol Methods; 2018 Dec; 155():82-88. PubMed ID: 30439465
[TBL] [Abstract][Full Text] [Related]
3. Using fecal immunochemical tubes for the analysis of the gut microbiome has the potential to improve colorectal cancer screening.
Krigul KL; Aasmets O; Lüll K; Org T; Org E
Sci Rep; 2021 Oct; 11(1):19603. PubMed ID: 34599256
[TBL] [Abstract][Full Text] [Related]
4. Alterations of circulating bacterial DNA in colorectal cancer and adenoma: A proof-of-concept study.
Xiao Q; Lu W; Kong X; Shao YW; Hu Y; Wang A; Bao H; Cao R; Liu K; Wang X; Wu X; Zheng S; Yuan Y; Ding K
Cancer Lett; 2021 Feb; 499():201-208. PubMed ID: 33249197
[TBL] [Abstract][Full Text] [Related]
5. Systematic evaluation of supervised classifiers for fecal microbiota-based prediction of colorectal cancer.
Ai L; Tian H; Chen Z; Chen H; Xu J; Fang JY
Oncotarget; 2017 Feb; 8(6):9546-9556. PubMed ID: 28061434
[TBL] [Abstract][Full Text] [Related]
6. Fecal Microbiota Characteristics of Patients with Colorectal Adenoma Detected by Screening: A Population-based Study.
Goedert JJ; Gong Y; Hua X; Zhong H; He Y; Peng P; Yu G; Wang W; Ravel J; Shi J; Zheng Y
EBioMedicine; 2015 Jun; 2(6):597-603. PubMed ID: 26288821
[TBL] [Abstract][Full Text] [Related]
7. The Role of Fecal
Liu K; Yang X; Zeng M; Yuan Y; Sun J; He P; Sun J; Xie Q; Chang X; Zhang S; Chen X; Cai L; Xie Y; Jiao X
Dis Markers; 2021; 2021():1171239. PubMed ID: 34853619
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.
Gao R; Wang Z; Li H; Cao Z; Gao Z; Chen H; Zhang X; Pan D; Yang R; Zhong H; Shen R; Yin L; Jia Z; Shen T; Qin N; Hu Z; Qin H
J Gastroenterol Hepatol; 2020 Dec; 35(12):2109-2121. PubMed ID: 32337748
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of the Discriminatory Ability of Combined Fecal Microbiota Panel in the Early Detection of Patients with Colorectal Cancer.
Amini M; Rezasoltani S; Asadzadeh Aghdaei H; Pourhoseingholi MA; Zali MR
J Gastrointest Cancer; 2024 Mar; 55(1):332-343. PubMed ID: 37566155
[TBL] [Abstract][Full Text] [Related]
10. Alterations in Enteric Virome Are Associated With Colorectal Cancer and Survival Outcomes.
Nakatsu G; Zhou H; Wu WKK; Wong SH; Coker OO; Dai Z; Li X; Szeto CH; Sugimura N; Lam TY; Yu AC; Wang X; Chen Z; Wong MC; Ng SC; Chan MTV; Chan PKS; Chan FKL; Sung JJ; Yu J
Gastroenterology; 2018 Aug; 155(2):529-541.e5. PubMed ID: 29689266
[TBL] [Abstract][Full Text] [Related]
11. Systematic review: Gut microbiota in fecal samples and detection of colorectal neoplasms.
Amitay EL; Krilaviciute A; Brenner H
Gut Microbes; 2018 Jul; 9(4):293-307. PubMed ID: 29543545
[TBL] [Abstract][Full Text] [Related]
12. Early Detection of Colorectal Cancer: a Multi-Center Pre-Clinical Case Cohort Study for Validation of a Combined DNA Stool Test.
Dollinger MM; Behl S; Fleig WE
Clin Lab; 2018 Oct; 64(10):1719-1730. PubMed ID: 30336540
[TBL] [Abstract][Full Text] [Related]
13. Altered Gut Archaea Composition and Interaction With Bacteria Are Associated With Colorectal Cancer.
Coker OO; Wu WKK; Wong SH; Sung JJY; Yu J
Gastroenterology; 2020 Oct; 159(4):1459-1470.e5. PubMed ID: 32569776
[TBL] [Abstract][Full Text] [Related]
14. Potential of fecal microbiota for detection and postoperative surveillance of colorectal cancer.
Yao Q; Tang M; Zeng L; Chu Z; Sheng H; Zhang Y; Zhou Y; Zhang H; Jiang H; Ye M
BMC Microbiol; 2021 May; 21(1):156. PubMed ID: 34044781
[TBL] [Abstract][Full Text] [Related]
15. The human gut microbiome as a screening tool for colorectal cancer.
Zackular JP; Rogers MA; Ruffin MT; Schloss PD
Cancer Prev Res (Phila); 2014 Nov; 7(11):1112-21. PubMed ID: 25104642
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated fecal microbial markers in colorectal cancer detection.
Eklöf V; Löfgren-Burström A; Zingmark C; Edin S; Larsson P; Karling P; Alexeyev O; Rutegård J; Wikberg ML; Palmqvist R
Int J Cancer; 2017 Dec; 141(12):2528-2536. PubMed ID: 28833079
[TBL] [Abstract][Full Text] [Related]
17. Using serum placenta growth factor could improve the sensitivity of colorectal cancer screening in fecal occult blood negative population: A multicenter with independent cohort validation study.
Wei SC; Tsao PN; Wang YT; Lin BR; Wu DC; Tsai WS; Chen JS; Wong JM
Cancer Med; 2019 Jul; 8(7):3583-3591. PubMed ID: 31063258
[TBL] [Abstract][Full Text] [Related]
18. Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis.
Iannone A; Losurdo G; Pricci M; Girardi B; Massaro A; Principi M; Barone M; Ierardi E; Di Leo A
J Gastrointest Cancer; 2016 Jun; 47(2):143-51. PubMed ID: 26922358
[TBL] [Abstract][Full Text] [Related]
19. Gene expression analysis using a highly sensitive DNA microarray for colorectal cancer screening.
Koga Y; Yamazaki N; Takizawa S; Kawauchi J; Nomura O; Yamamoto S; Saito N; Kakugawa Y; Otake Y; Matsumoto M; Matsumura Y
Anticancer Res; 2014 Jan; 34(1):169-76. PubMed ID: 24403458
[TBL] [Abstract][Full Text] [Related]
20. Fecal occult blood test in colorectal cancer screening.
Li JN; Yuan SY
J Dig Dis; 2019 Feb; 20(2):62-64. PubMed ID: 30714325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
